Expression, Purification, and Characterization of a Catalytically Active Human Cytochrome P450 1A2:Rat NADPH-Cytochrome P450 Reductase Fusion Protein

This publication has 36 references indexed in Scilit:

• Construction of a Human Cytochrome P450 1A1:Rat NADPH–Cytochrome P450 Reductase Fusion Protein cDNA and Expression inEscherichia coli,Purification, and Catalytic Properties of the Enzyme in Bacterial Cells and after Purification
  Archives of Biochemistry and Biophysics, 1996
• Recombinant Human Cytochrome P450 1A2 and an N-Terminal-Truncated Form: Construction, Purification, Aggregation Properties, and Interactions with Flavodoxin, Ferredoxin, and NADPH-Cytochrome P450 Reductase
  Archives of Biochemistry and Biophysics, 1996
• New Applications of Bacterial Systems to Problems in Toxicology
  Critical Reviews in Toxicology, 1996
• Roles of Divalent Metal Ions in Oxidations Catalyzed by Recombinant Cytochrome P450 3A4 and Replacement of NADPH-Cytochrome P450 Reductase with Other Flavoproteins, Ferredoxin, and Oxygen Surrogates
  Biochemistry, 1995
• Regulation of steroid hydroxylase gene expression: Importance to physiology and disease
  Pharmacology & Therapeutics, 1993
• Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.
  Proceedings of the National Academy of Sciences, 1993
• Metabolic activation of carcinogens
  Pharmacology & Therapeutics, 1992
• A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin.
  Journal of Clinical Investigation, 1991
• THE MOLECULAR GENETICS OF 21-HYDROXYLASE DEFICIENCY
  Annual Review of Genetics, 1989
• GENETICALLY DETERMINED DEFECTS OF OXIDATION AT CARBON CENTRES OF DRUGS
  The Lancet, 1978